SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

TFF Pharmaceuticals, Inc. TFFP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

TFF Pharmaceuticals, Inc. (TFFP) is a Biotechnology company in the Healthcare sector, currently trading at $0.07. It has a SharesGrow Score of 42/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $733,871, +0%/yr average growth. Net income is $21M (loss), growing at -12.5%/yr. Net profit margin is -2894.7% (negative). Gross margin is 31.5% (+0 pp trend).

Balance sheet: total debt is $115,254 against $10M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.13 (strong liquidity). Debt-to-assets is 1%. Total assets: $12M.

Analyst outlook: 5 / 5 analysts rate TFFP as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 32/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).

TFFP SharesGrow Score Overview

51/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 15/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 32/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TFFP

No analyst coverage available for this stock.

TFFP: +0%/yr revenue is, -12.5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet TFFP: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 3.13 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

TFFP: Gross margin is 31.5% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 32/100. ≥ 70 = Pass.

View details →

Analyst outlook: 5 / 5 analysts rate TFFP as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

TFFP: Net profit margin is -2894.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.061-11.0

Volume11.02M

Avg Volume (30D)1.69M

Market Cap$288.8K

Beta (1Y)1.32

Share Statistics

EPS (TTM)-11.85

Shares Outstanding$1.79M

IPO Date2019-10-25

Employees19

CEOHarlan F. Weisman

Financial Highlights & Ratios

Revenue (TTM)$733.87K

Gross Profit$231.39K

EBITDA$-20.74M

Net Income$-21.24M

Operating Income$-21.89M

Total Cash$5.48M

Total Debt$115.25K

Net Debt$-5.36M

Total Assets$12.03M

Price / Earnings (P/E)-0

Price / Sales (P/S)0.39

Analyst Forecast

Rating ConsensusBuy

Analysts Covering5

Buy 100% Hold 0% Sell 0%

Company Info

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS87241J2033

Price Chart

TFFP

TFF Pharmaceuticals, Inc. ↗ · NASDAQ Global Market

Healthcare • Biotechnology

0.06 52WK RANGE 11.00

People Also View

aTyr Pharma, Inc.

Anixa Biosciences, Inc.

AN2 Therapeutics, Inc.

Gain Therapeutics, Inc.

Cognition Therapeutics, Inc.

TScan Therapeutics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message